| ARQT Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ARQT market cap history going back to 1/31/2020:
Also see: ARQT Shares Outstanding History and ARQT YTD Return |
ARQT Market Cap History — Arcutis Biotherapeutics Capitalization Over Time
As of 4/30/2026 Arcutis Biotherapeutics has a market cap of 2.90 billion. Investors often follow the ARQT market cap history to compare the size of the company over time.
This page shows ARQT market capitalization trends over time, with 25 market cap datapoints presented, dating back to 1/31/2020.
| ARQT Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||
ARQT Historical Market Cap: +23.83% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| ARQT Stock Price Chart |
| About Arcutis Biotherapeutics Inc |
| Arcutis Biotherapeutics, Inc. is a commercial-stage medical dermatology company. Co. is focused on developing and commercializing treatments for dermatological diseases with high-unmet medical needs. Its portfolio is comprised of topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. Its lead product, ZORYVE, is for the treatment of plaque psoriasis, including psoriasis in the intertriginous areas, in individuals 12 years of age or older. ZORYVE cream is a once-daily topical formulation of roflumilast, a potent and selective phosphodiesterase-4 (PDE4) inhibitor. Co.'s pipeline includes ARQ-255, ARQ-252, and ARQ-234. We show 25 historical shares outstanding datapoints in our ARQT shares outstanding history coverage, used to compute ARQT market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ARQT market cap history over the course of time is important for investors interested in comparing ARQT's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ARQT versus a peer is one thing; comparing ARQT market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ARQT can fluctuate over the course of history. With this page we aim to empower investors researching ARQT by allowing them to research the ARQT market cap history. |
| ARQT Current Stock Quote |
Quotes delayed 20 minutes  Free ARQT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| ARQT Share Performance |
| Market Cap Peers |
| Arcutis Biotherapeutics (ARQT) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
ARTL Market Cap History ARTV Market Cap History ARVN Market Cap History ARWR Market Cap History ASMB Market Cap History ASPI Market Cap History ASRT Market Cap History ASTH Market Cap History ATAI Market Cap History ATEC Market Cap History More Healthcare companies » |
ARQT Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
